A significant breakthrough in cancer study is occurring with the use of VHH fragments to reactivate mutated p53. This vital malignant protector protein is frequently inactivated in many kinds of tumors, leading https://bookmarkleader.com/story21986929/mini-antibodies-revive-p53-the-potential-approach-for-tumor-management